SCHEMBL3409992

SCHEMBL3409992

O=C(O)c1cccc(NC(=O)c2c(=O)[nH]n3c(=O)c4c([nH]c23)CCCC4)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.50
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
EGFR P00533 2/20 0.45
MEN1 O00255 8/20 0.44
KMT2A Q03164 8/20 0.44
MAPT P10636 5/20 0.44
LMNA P02545 4/20 0.44
HPGD P15428 3/20 0.44
HTT P42858 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
BLM P54132 2/20 0.44
CTDSP1 Q9GZU7 2/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
L3MBTL1 Q9Y468 5/20 0.44
TDP1 Q9NUW8 4/20 0.44
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3410031 0.89 MAPT (0.52) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3410083 0.81 LMNA (0.48) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3411680 0.81 MAPT (0.47) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3411765 0.79 MAPT (0.43) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3408224 0.77 MAPT (0.50) POLBMEN1KMT2AMAPTLMNA
SCHEMBL3411768 0.77 MAPT (0.46) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3411549 0.76 NPC1 (0.49) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3405825 0.76 MAPT (0.55) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3408312 0.76 TDP1 (0.49) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL2637592 0.75 MEN1 (0.45) NPC1RAB9AEGFRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP claimed
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed